Clinical Trial Update: Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Polydiuretic Therapy for heart failure with preserved ejection fraction and diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Polydiuretic Therapy

Snippet

Sponsor: Northwestern University | Conditions: HF - Heart Failure, Diabetes Mellitus | Phase 4 | Status: WITHDRAWN